Pharmaceuticals - Community Register


Community list of not active veterinary medicinal products


Product information

Invented name: Recuvyra
Auth. number : EU/2/11/127
Active substance : Fentanyl
ATC: Anatomical main group: QN - Nervous system
Therapeutic subgroup: QN02 - Analgesics
Pharmacological subgroup: QN02A - Opioids
Chemical subgroup: QN02AB - Phenylpiperidine derivatives
Chemical substance: QN02AB03 - fentanyl
(See WHO ATCvet Index)
Indication: For the control of post-operative pain associated with major orthopaedic and soft tissue surgery in dogs.
Marketing Authorisation Holder: Eli Lilly and Company Limited
Elanco Animal Health, Lilly House, Priestley Road, Basingstoke, Hampshire RG24 9NL, United Kingdom
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/10/2011 Centralised - Authorisation EMEA/V/C/2239 (2011)7246 of 06/10/2011
21/12/2011 Centralised - Variation EMEA/V/C/2239/IAIN/4
Updated with Decision(2012)1854 of 15/03/2012
20/03/2012 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/2239/T/5 (2012)1854 of 15/03/2012
28/05/2014 Centralised - Variation EMEA/V/C/2239/IG/437
Updated with Decision(2015)3936 of 05/06/2015
13/02/2015 Centralised - Variation EMEA/V/C/2239/IB/9/G
Updated with Decision(2015)3936 of 05/06/2015
09/06/2015 Centralised - Yearly update (2015)3936 of 05/06/2015
11/10/2016 Centralised - Withdrawal (not renewed)